These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 25358029
1. A statistical approach to determining criticality of residual host cell DNA. Yang H, Wei Z, Schenerman M. J Biopharm Stat; 2015; 25(2):234-46. PubMed ID: 25358029 [Abstract] [Full Text] [Related]
2. Guest editors' note: special issue on recent developments in statistical approaches for chemistry and manufacturing control (CMC) and quality-by-design(QbD). Tsong Y, Yang H. J Biopharm Stat; 2015; 25(2):233. PubMed ID: 25437635 [No Abstract] [Full Text] [Related]
3. Statistical considerations in setting product specifications. Dong X, Tsong Y, Shen M. J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110 [Abstract] [Full Text] [Related]
10. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products. Tsong Y, Dong X, Shen M, Lostritto RT. J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132 [Abstract] [Full Text] [Related]
11. Testing assay linearity over a pre-specified range. Yang H, Novick SJ, LeBlond D. J Biopharm Stat; 2015; 25(2):339-50. PubMed ID: 25356663 [Abstract] [Full Text] [Related]
12. A direct qPCR method for residual DNA quantification in monoclonal antibody drugs produced in CHO cells. Hussain M. J Pharm Biomed Anal; 2015 Nov 10; 115():603-6. PubMed ID: 25850374 [Abstract] [Full Text] [Related]
14. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design. Martin-Moe S, Lim FJ, Wong RL, Sreedhara A, Sundaram J, Sane SU. J Pharm Sci; 2011 Aug 10; 100(8):3031-3043. PubMed ID: 21425164 [Abstract] [Full Text] [Related]
15. Optimization and validation of DNA extraction and real-time PCR assay for the quantitative measurement of residual host cell DNA in biopharmaceutical products. Hu B, Sellers J, Kupec J, Ngo W, Fenton S, Yang TY, Grebanier A. J Pharm Biomed Anal; 2014 Jan 10; 88():92-5. PubMed ID: 24042121 [Abstract] [Full Text] [Related]
16. A probabilistic model for risk assessment of residual host cell DNA in biological products. Yang H, Zhang L, Galinski M. Vaccine; 2010 Apr 26; 28(19):3308-11. PubMed ID: 20226252 [Abstract] [Full Text] [Related]
18. Specific detection of residual CHO host cell DNA by real-time PCR. Nissom PM. Biologicals; 2007 Jun 26; 35(3):211-5. PubMed ID: 17071102 [Abstract] [Full Text] [Related]
19. Manufacturing history of etanercept (Enbrel®): Consistency of product quality through major process revisions. Hassett B, Singh E, Mahgoub E, O'Brien J, Vicik SM, Fitzpatrick B. MAbs; 2018 Jan 26; 10(1):159-165. PubMed ID: 29020515 [Abstract] [Full Text] [Related]
20. Safety assessment of Madin Darby canine kidney cells as vaccine substrate. Medema JK, Meijer J, Kersten AJ, Horton R. Dev Biol (Basel); 2006 Jan 26; 123():243-50; discussion 265-6. PubMed ID: 16566450 [Abstract] [Full Text] [Related] Page: [Next] [New Search]